dockets: FDA-2003-P-0408

Regulatory dockets from Regulations.gov — containers for related documents and comments in a rulemaking proceeding.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id title docket_type last_modified object_id
FDA-2003-P-0408 FDA to request the commissioner of Food and Drugs to determine that Lovenox(enoxaparin sodlium),NDA 20-164(90mg/0.6ml)Product Number 006),sponsored by Aventis Pharmaceuticals Inc.(Aventis), was not withdrawn from sale for reasons of safety of effectiveness. Nonrulemaking 2021-09-01T01:03:18Z 0b000064804a1af4

Links from other tables